UC San Diego Sulpizio Cardiovascular Center is now offering patients with atrial fibrillation the breakthrough benefits of heat energy, or radio frequency waves, to irreversibly alter heart tissue that triggers an abnormal heart rhythm or arrhythmia. The THERMOCOOL SF Catheter is an FDA-approved outpatient procedure for an early-stage form of the condition called paroxysmal atrial fibrillation, when recurring symptoms are unresponsive to medicine. Patients typically experience rapid heartbeats that can lead to debilitating fatigue, dizziness, fainting or shortness of breath if left untreated.
- Environmental Sciences - 11:00 The burning issue of the world’s vulnerable carbon sinks
- Business - 08:00 Novartis delivered solid sales growth, margin expansion and pipeline progress in 2014; portfolio transformation will focus company on leading businesses
- Administration - 07:01 Youngest children and poorer households worst hit by Coalition’s selective cuts
- Agronomy - 07:01 Scientists call for soil mapping program to help Indian agriculture
- Medicine - 06:01 Study explores historical influences on health policy
- Life Sciences - Jan 27 Biology, driven by data
- Medicine - Jan 27 Is the medical match fair?
- Life Sciences - Jan 27 Sharks aren't criminals, but our fear makes us talk as if they are
- Astronomy - Jan 26 Rosetta watches comet shed its dusty coat
- Business - Jan 26 Identify HR’s role for M&A deals to succeed
- Medicine - Jan 26 Study explores key influences on British health policy
- Literature - Jan 26 One in five online scholarly articles affected by ’reference rot’
- Law - Jan 26 Does the First Amendment need a New Deal?
- Computer Science - Jan 26 Researcher talks about his involvement in the film Ex-Machina
- History - Jan 26 Site of Brunel’s ss Great Britain ‘shipwreck’ located in Northern Ireland
- Astronomy - Jan 26 Satellites for peat’s sake
UCSD Uses Heat Energy to Fix Odd Heart Beat
"Atrial fibrillation has a devastating impact on more than 2.7 million Americans, yet for many patients unresponsive to medication, traditional treatment options are limited," said Gregory Feld, MD, professor of medicine at University of California, San Diego and Director of the Cardiac Electrophysiology Program at UC San Diego Sulpizio Cardiovascular Center. "This catheter ablation technology is the latest treatment alternative for patients dealing with the disabling effects of cardiac arrhythmias, such as paroxysmal atrial fibrillation. This is a viable option for patients who do not benefit from their first medication."
Atrial fibrillation causes the upper heart chambers to beat rapidly and uncontrollably, and is characterized by disorganized electrical activity in the heart. This results in an irregular pulse, and sometimes a "fluttering" feeling in the chest. An episode can last just seconds, or occur for minutes, hours or even days. Paroxysmal atrial fibrillation is an early-stage form of the condition, where episodes occur repeatedly but stop on their own, often in a few hours or less.
Performed by an electrophysiologist (EP), catheter ablation is a non-surgical procedure that addresses the underlying cause of arrhythmias. In real time, the clinician first pinpoints the source of irregular electrical activity using a 3-D mapping system, similar to a GPS device in your car. Guided by this map, the clinician directs a specialized catheter through the heart to the source of the abnormal electrical impulses. A small electrode in the tip of the catheter generates radio frequency waves that have enough heat to alter targeted areas of heart tissue. This process blocks the electrical impulses that can cause heart rhythm disorders.
Unlike traditional catheter technologies, the THERMOCOOL SF catheter uniformly delivers a cooling saline solution through the catheter, allowing for cooling of the entire catheter tip. Thus, the tip temperature does not rise significantly during ablation, which reduces the risk for clotting, and enhances treatment safety.
This outpatient procedure takes approximately two-to-four hours, with some patients returning home the next day. The result is either a long-term reduction in the number of arrhythmias experienced and the severity of symptoms, or a permanent return to a more normal heart rhythm.
Atrial fibrillation is growing in prevelance. Up to 12 million Americans will have the condition by 2050. While not life-threatening, atrial fibrillation is a leading cause of stroke among people 65 years and older.
Last job offers
- Microtechnics - 26.1
Senior R&D Engineer
- Microtechnics - 25.1
Dozentin / Dozent Energietechnik mit Forschungsanteil
- Psychology - 23.1
PhD positions Psychopathologie & Klinische Intervention UZH
- Civil Engineering - 22.1
Assistente in Ingegneria edile / civile o in architettura
- Social Sciences - 22.1
Führungspersönlichkeit (Vizedirektor/in) für das Zentrum für Lehre
- Business - 21.1
Consultant im Bereich int. Handel- und Transportwesen 100%
- Microtechnics - 26.1
Assistant Professor of Bioelectronics
- Mechanical Engineering - 26.1
Assistant Professor of Aircraft Propulsion
- Business - 13.1
Professur (m/w) - Innovationsnetzwerke (20h)
- Computer Science - 3.12
Universitätsprofessur für Informatik und deren Didaktik am Institut für Informatikdidaktik
- Life Sciences - 26.1
Professur "Molekulare Genetik" im Fachbereich Biologie
- Pedagogy - 26.1
Professur Ökonomie und ökonomische Bildung am Institut für Sprach-, Literatur- und Sozialwissenschaften...
- Computer Science - 26.1
Associate Professorship (or Professorship) of Computer Science (Algorithms)
- Literature - 26.1
Marshal Foch Professor of French Literature
- Medicine - 27.1
- Literature - 26.1
Visiting Principal Cataloger and Visiting Assistant Professor - Rare Book and Manuscript Library (F1500005)...